Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

4,122.00p
   
  • Change Today:
    -70.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 4,122.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 121,824
  • Market Cap: £2,711.04m
  • RiskGrade: 128
  • Beta: 0.05

Genus Overview

Genus applies science to animal breeding. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors. It is a provider of bovine genetics and reproduction services, marketing in more than 70 countries.
Registrars: Equiniti

Key Personnel

Non-Executive Chairman: Iain Ferguson
CEO: Stephen Wilson
CFO: Alison Henriksen
Independent Non-Executive Director: Lysanne Gray
Independent Non-Executive Director: Jason Chin
Independent Non-Executive Director: Lykele van der Broek
Senior Independent Director: Lesley Knox
Non-Executive Dir:

Contact Details

Address: Matrix House, Basing View, Basingstoke, Hampshire, United Kingdom, RG21 4DZ
Phone: +44 (0) 1256 347 100
Fax: +44 (0) 1256 477 385
Website: http://www.genusplc.com

Listings

Sector: Pharma and Biotech(LSE)
Index: techMARK, FTSE 250, FTSE 350, FTSE All-Share, FTSE techMARK Focus
Overseas Listings: BATSLON:GNSL
ISIN: GB0002074580

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 4,122.00p
Change Today -70.00p
% Change -1.67 %
52 Week High 6,070.00
52 Week Low 4,122.00
Volume 121,824
Shares Issued 65.77m
Market Cap £2,711.04m
Beta 0.05
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.66% below the market average96.66% below the market average96.66% below the market average96.66% below the market average96.66% below the market average
95.92% below the sector average95.92% below the sector average95.92% below the sector average95.92% below the sector average95.92% below the sector average
Price Trend
29.82% below the market average29.82% below the market average29.82% below the market average29.82% below the market average29.82% below the market average
9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average
Income
88.48% below the market average88.48% below the market average88.48% below the market average88.48% below the market average88.48% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Growth
80.43% above the market average80.43% above the market average80.43% above the market average80.43% above the market average80.43% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 2
Sell 0
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 18-Nov-21 04-Mar-21
Paid 10-Dec-21 01-Apr-21
Amount 21.70p 10.30p

Trades for 14-Jan-2022

Time Volume / Share Price
16:35 31,387 @ 4,122.00p
16:29 1 @ 4,146.00p
16:29 8 @ 4,146.00p
16:29 21 @ 4,144.00p
16:29 24 @ 4,144.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page